Currently, there are 215.30M common shares owned by the public and among those 209.87M shares have been available to trade.
Insiders at the company have transacted a total of 92 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 78 of these insider trades were purchases, accounting for 234,830 shares. Insider sales of the common stock occurred on 14 occasions, with total insider shares sold totaling 63,067 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 34.21, up 2.49%. The company’s stock has a 5-day price change of -2.48% and 16.95% over the past three months. XRAY shares are trading -4.02% year to date (YTD), with the 12-month market performance down to -11.13% lower. It has a 12-month low price of $26.27 and touched a high of $43.24 over the same period. XRAY has an average intraday trading volume of 3.23 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.73%, -0.42%, and -5.50% respectively.
Institutional ownership of DENTSPLY Sirona Inc (NASDAQ: XRAY) shares accounts for 100.31% of the company’s 215.30M shares outstanding.
It has a market capitalization of $7.24B and a beta (3y monthly) value of 1.02. The earnings-per-share (ttm) stands at -$1.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.46% over the week and 2.47% over the month.
Analysts forecast that DENTSPLY Sirona Inc (XRAY) will achieve an EPS of $DENTSPLY SIRONA Inc. for the current quarter, $34.16 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $NEOS ETF Trust FIS Christian St while analysts give the company a high EPS estimate of $XRA. Comparatively, EPS for the current quarter was $CRAY a year ago. Earnings per share for the fiscal year are expected to decrease by -12.74%, and 11.64% over the next financial year. EPS should shrink at an annualized rate of 8.00% over the next five years, compared to 8.19% over the past 5-year period.
Looking at the support for the XRAY, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on November 16, 2023, with the firm’s price target at $35.
